4//SEC Filing
GARRETT J STEVEN 4
Accession 0001260651-04-000014
CIK 0000809875other
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 12:31 PM ET
Size
8.9 KB
Accession
0001260651-04-000014
Insider Transaction Report
Form 4
GARRETT J STEVEN
Senior VP Clinical Research
Transactions
- Exercise/Conversion
Common Stock, $.001 Par Value
2004-09-13$12.88/sh+5,000$64,375→ 8,500 total - Sale
Common Stock, $.001 Par Value
2004-09-13$30.00/sh−5,000$150,000→ 3,500 total - Exercise/Conversion
Stock Option (Right-To-Buy)
2004-09-13$12.88/sh−5,000$64,375→ 3,800 totalExercise: $12.88From: 2001-08-18Exp: 2010-08-18→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Documents
Issuer
ATRIX LABORATORIES INC
CIK 0000809875
Entity typeother
Related Parties
1- filerCIK 0001260651
Filing Metadata
- Form type
- 4
- Filed
- Sep 13, 8:00 PM ET
- Accepted
- Sep 14, 12:31 PM ET
- Size
- 8.9 KB